Author

E. P. Gniffke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. M. Adeyemi· 1 shared D. N. E. P. Sather· 1 shared J. K. Walker· 1 shared K. B. Tsegay· 1 shared S. E. P. Smith· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. M. Adeyemi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2

K. B. Tsegay, C. M. Adeyemi, E. P. Gniffke, D. N. E. P. Sather, J. K. Walker, S. E. P. Smith

The paper screens 2701 approved drugs to find those inhibiting SARS-CoV-2 spike protein binding to ACE2, identifying 56 compounds with >90% inhibition and modeling their docking.

bioRxiv · Apr 8, 2021Pharmacology & Toxicology